Skip to content

Study · Measured the body's own peptide · 2023

1 result

Thymus transplantation regulates blood pressure and alleviates hypertension-associated heart and kidney damage via transcription factors FoxN1 pathway.

Dai X, Zhao J, Hua L, Chen H, Liang C

International immunopharmacology2 Feb 2023Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In hypertensive mice, the expression of thymosin β4 in the thymus was decreased compared with the other two groups.

    In plain wordsIn mice with high blood pressure, the thymus made less of the body's own thymosin β4 than in the other two groups.

    Outcome
    DecreaseThymic Tβ4 expression in hypertensive mice
    Study

    mousen: not reported in source

    Comparator
    Control and transplantation groups
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The expression of FoxN1, Aire, ATRAP, thymosin β4 and the content of sjTREC in thymus of HTN group was decreased
    2 context sentences
    Summary · context
    Mice were randomly divided into normal control group (Con), hypertensive group (HTN) and thymus transplantation group (HTN + Trans).
    Summary · context
    Thymus of neonatal mice was transplanted into the renal capsule of the transplantation group.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.